abstract |
The present invention relates to a sphingosine kinase inhibitor comprising a compound represented by formula (I) [wherein each symbol is as defined in the description] or a salt thereof, and provides a compound useful for the prevention and/or treatment of inflammatory bowel disease and the like. |